Misuse of Drugs Regulations 2017 – S.I. No. 173 of 2017
These Regulations apply controls to the groups of drugs specified in Schedules 1 to 5 of the Regulations (being drugs to which the Misuse of Drugs Acts 1977 to 2016 apply). The effect of the Regulations is to impose restrictions on the production, supply, importation and exportation of the drugs in question, which vary according to the extent to which these drugs are used for medical or scientific purposes and having regard to the likelihood of their being abused. Appropriate exemptions are provided to cover legitimate use for professional purposes by doctors, pharmacists, nurses and midwives, veterinary practitioners, prison officers, etc. and in other specified circumstances.
In addition to these controls the Regulations specify the classes of persons who may have controlled drugs in their possession and the circumstances in which such possession would not be in contravention of the Act.
The Regulations contain other miscellaneous provisions such as requirements as to the form of prescriptions for controlled drugs, the keeping of books and records, proper documentation relating to export of controlled drugs, arrangements for destruction or disposal of such drugs, and provisions regarding possession of forged prescriptions.
The Regulations also prescribe certain controlled drugs for the purposes of section 5 of the Misuse of Drugs Act 1984.
The Regulations confer authority on certain inspectors, in the Department of Agriculture, Food and the Marine, to lawfully possess Cannabis (hemp) in the course of their duties while monitoring and sampling for the purpose of the relevant EU scheme involving the grant of aid for the production of hemp fibre.
S.I. No. 173 of 2017